Search
Close this search box.

RNA Insights

Dive into our team's latest insights about life sciences deal making, transaction support and value creation.

Why Valuation Matters in Early-Stage Life Sciences

“Value”, the outcome of a thorough valuation analysis,... [read more]

Adaptive Valuation Approaches in Life Sciences and Healthcare

In finance, theories about the efficiency of markets... [read more]

Client Success: Derivatives Valuation for pre-IPO Biotechnology Company

THE PROBLEM: A development stage biotechnology company (considering... [read more]

Client Success: Commercial Assessment for Crossover Investor-Funded Private Biotech

THE PROBLEM: Novel technology platform could be used... [read more]

Client Success: Valuation Support for Licensing Transaction – Novel Cancer Therapy

THE PROBLEM: Publicly traded late-stage therapeutics company negotiates... [read more]

Client Success: Valuation Analysis for Revenue Cycle Healthcare Technology Spin-Out

THE PROBLEM: Determine the fair market value of... [read more]

Client Success: Portfolio Valuation for LPs of $1B + Healthcare-Focused PE Firm

THE PROBLEM: Two of the largest pension funds... [read more]

Sign Up for Periodic Updates

Enter your email address below to receive updates from RNA Advisors.